Incidental hepatic steatosis on unenhanced computed tomography performed for suspected renal colic: Gaps in reporting and documentation.


Journal

Journal of medical imaging and radiation oncology
ISSN: 1754-9485
Titre abrégé: J Med Imaging Radiat Oncol
Pays: Australia
ID NLM: 101469340

Informations de publication

Date de publication:
Aug 2019
Historique:
received: 25 11 2018
accepted: 17 02 2019
pubmed: 16 3 2019
medline: 8 2 2020
entrez: 16 3 2019
Statut: ppublish

Résumé

Hepatic steatosis is a common incidental finding on computed tomography (CT) in patients presenting to the emergency department (ED). The aims of our study were to assess the prevalence of hepatic steatosis in ED patients with suspected renal colic and to assess documentation in radiology reports and medical charts correlated with alanine transaminase (ALT) levels. Over 18 months from January 2016 to June 2017, all unenhanced CTs performed for suspected renal colic were reviewed. Quantitative assessment measuring hepatic and splenic attenuation in Hounsfield Units was performed. Hepatic steatosis was defined using multiple CT criteria including liver/spleen (L/S) ratio. Radiology reports, medical charts and ALT levels, if collected within 24 h of CT, were reviewed. A total of 1290 patients were included with a median age 52.5 years (range 16-98) and male predominance (835 [64.7%]). A total of 336 (26%) patients had hepatic steatosis measured by L/S ratio of ≤ 1.0. Ninety-four patients (28%) had radiology reports noting steatosis. Documentation in medical charts was noted in 18 of the 94 patients (19.1%) for whom steatosis was reported. Liver enzymes were available for 704 (54.6%) patients. There was a significantly higher mean ALT level in patients with hepatic steatosis (42.2 U/L; 95% CI 38.4-46.0) compared to patients without (28.8 U/L; 95% CI 25.7-31.9) (P < 0.0001). Our findings highlight multiple gaps in the reporting and evaluation of hepatic steatosis among radiologists and emergency clinicians alike. Recognising and reporting this incidental finding may impact health outcomes.

Identifiants

pubmed: 30874372
doi: 10.1111/1754-9485.12873
doi:

Substances chimiques

Alanine Transaminase EC 2.6.1.2

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

431-438

Informations de copyright

© 2019 The Royal Australian and New Zealand College of Radiologists.

Auteurs

Numan Kutaiba (N)

Radiology Department, Austin Health, Melbourne, Victoria, Australia.

Danielle Richmond (D)

Radiology Department, Austin Health, Melbourne, Victoria, Australia.

Matthew Morey (M)

Radiology Department, Austin Health, Melbourne, Victoria, Australia.

Daniel Brennan (D)

Radiology Department, Austin Health, Melbourne, Victoria, Australia.

Joe-Anthony Rotella (JA)

Emergency Department, Austin Health, Melbourne, Victoria, Australia.
The University of Melbourne, Melbourne, Victoria, Australia.

Zaid Ardalan (Z)

Gastroenterology Department, Austin Health, Melbourne, Victoria, Australia.
Gastroenterology Department, Alfred Health and Monash University, Melbourne, Victoria, Australia.

Mark Goodwin (M)

Radiology Department, Austin Health, Melbourne, Victoria, Australia.
The University of Melbourne, Melbourne, Victoria, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH